Revenue by source
Cardiac and Vascular Group$13.98BNeuroscience Group$10.29BMedical Surgical$8.82BMinimally Invasive Therapies Group$0.00Diabetes Group$3.11BRestorative Therapies Group$0.00Cardiovascular Portfolio$0.00Medical Surgical Portfolio$0.00Neuroscience Portfolio$0.00Diabetes Operating Unit$0.00
| Segment | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Cardiac and Vascular Group | $9.36B | $10.20B | $10.50B | $11.35B | $11.51B | $10.47B | - | $11.42B | $11.57B | $11.83B | $12.48B | $13.98B |
| Neuroscience Group | - | - | - | - | - | - | - | $8.78B | $8.96B | $9.41B | $9.85B | $10.29B |
| Medical Surgical | - | - | - | - | - | - | - | $9.14B | $8.43B | $8.42B | $8.41B | $8.82B |
| Minimally Invasive Therapies Group | - | - | - | $8.72B | $8.48B | $8.35B | - | - | - | - | - | - |
| Diabetes Group | $1.76B | $1.86B | $1.93B | $2.14B | $2.39B | $2.37B | - | $2.34B | $2.26B | $2.49B | $2.76B | $3.11B |
| Restorative Therapies Group | - | - | - | $7.74B | $8.18B | $7.73B | - | - | - | - | - | - |
| Cardiovascular Portfolio | - | - | - | - | - | - | $10.77B | - | - | - | - | - |
| Medical Surgical Portfolio | - | - | - | - | - | - | $8.74B | - | - | - | - | - |
| Neuroscience Portfolio | - | - | - | - | - | - | $8.20B | - | - | - | - | - |
| Diabetes Operating Unit | - | - | - | - | - | - | $2.41B | - | - | - | - | - |
Revenue by country
UNITED STATES$71.40BTotal Other Countries, Excluding United States and Ireland$18.12BEMEA$0.00Asia Pacific$0.00CHINA$0.00IRELAND$143.00M
| Segment | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| UNITED STATES | $12.13B | $17.58B | $34.64B | $15.88B | $16.19B | $14.92B | $15.53B | $16.13B | $16.37B | $16.56B | $17.17B | $71.40B |
| Total Other Countries, Excluding United States and Ireland | - | - | - | $13.99B | $14.27B | $13.91B | $14.49B | $15.45B | $14.76B | $15.69B | $16.25B | $18.12B |
| EMEA | $5.06B | $6.70B | $6.74B | - | - | - | - | - | - | - | - | - |
| Asia Pacific | $2.06B | $3.06B | $3.44B | - | - | - | - | - | - | - | - | - |
| CHINA | $1.01B | $1.50B | $1.59B | - | - | - | - | - | - | - | - | - |
| IRELAND | - | - | - | $85.00M | $91.00M | $85.00M | $100.00M | $101.00M | $98.00M | $113.00M | $116.00M | $143.00M |